Heinrich Dreismann insider trades

Open-market stock purchases and sales by Heinrich Dreismann, Director at Myriad Genetics Inc, from SEC Form 4 filings since Jun 2, 2022.

Recent trades

DateStockTradeValue
Jun 4, 2026MYGN Myriad Genetics IncBought (not open market)—
Feb 13, 2026MYNZ Mainz Biomed NVBought (not open market)—

Companies traded

  • MYGN Myriad Genetics Inc: 1 sale, last Jun 4, 2026
  • MYNZ Mainz Biomed NV: other filings, last Feb 13, 2026
  • TLIS Talis Biomedical Corp: other filings, last Jun 9, 2023

Get free alerts when Heinrich Dreismann files a new trade →